Bioresorbable Scaffolds: Current Technology and Future Perspectives

Area of Science:

• Cardiovascular Medicine
• Biomaterials Science
• Interventional Cardiology

Background:

• Metallic drug-eluting stents (DES) improve clinical outcomes but cause vessel wall caging.
• Fully bioresorbable scaffolds (BRS) aim to eliminate long-term foreign material, enabling vessel recovery.
• Early BRS adoption faced challenges, including higher rates of scaffold thrombosis compared to metallic stents.

Purpose of the Study:

• To review current bioresorbable scaffold (BRS) technologies.
• To outline advancements in BRS design, implantation techniques, and patient management.
• To address the learning curve and safety concerns from initial BRS trials.

Main Methods:

• Review of current literature and clinical data on bioresorbable scaffold technologies.
• Analysis of refinements in scaffold design, including material, structure, and drug-elution.
• Evaluation of procedural strategies and post-procedural care protocols informed by early trial outcomes.

Main Results:

• Significant improvements in BRS design have been achieved to enhance mechanical properties and resorption profiles.
• Optimized procedural techniques and lesion selection criteria have been developed to minimize procedural risks.
• Enhanced post-procedural care strategies have been implemented to mitigate adverse events like scaffold thrombosis.

Conclusions:

• Bioresorbable scaffolds (BRS) represent a promising advancement over metallic stents, offering a 'leave nothing behind' solution.
• Continuous innovation in BRS technology, coupled with refined clinical practices, is crucial for improving patient outcomes.
• The evolution of BRS technology addresses earlier concerns, paving the way for wider clinical acceptance.